InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Erick Lucera, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 6 open-market SEC Form 4 transactions: 2 purchases worth $29K and 4 sales worth $207K, reported from Mar 16, 23 to Jun 25, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 26 | DYNDyne Therapeutics, Inc. | SELL | 2.4K | $20.37 | $48K |
| May 13, 26 | DYNDyne Therapeutics, Inc. | SELL | 1.4K | $18.36 | $27K |
| Mar 4, 25 | EDITEditas Medicine, Inc. | SELL | 4.1K | $1.71 | $7K |
| Aug 14, 24 | XAIRBeyond Air, Inc. | BUY | 39.3K | $0.40 | $16K |
| May 20, 24 | EDITEditas Medicine, Inc. | SELL | 22.3K | $5.61 | $125K |
| Mar 16, 23 | XAIRBeyond Air, Inc. | BUY | 2.0K | $6.82 | $14K |